Global Canine Cancer Screening Market Growth (Status and Outlook) 2026-2032
The global Canine Cancer Screening market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Canine cancer screening is a process used to detect cancer in dogs at an early stage, often before symptoms become noticeable. Early detection can significantly improve the chances of successful treatment. Screening methods may include blood tests, imaging (such as X-rays or ultrasounds), and physical exams. Recently, there has also been progress in genetic testing and liquid biopsy techniques, which involve detecting cancer-related DNA or biomarkers in a dog's blood sample.
United States market for Canine Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Canine Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Canine Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Canine Cancer Screening players cover IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Canine Cancer Screening Industry Forecast” looks at past sales and reviews total world Canine Cancer Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Cancer Screening sales for 2026 through 2032. With Canine Cancer Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Cancer Screening industry.
This Insight Report provides a comprehensive analysis of the global Canine Cancer Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Canine Cancer Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Canine Cancer Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Cancer Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Cancer Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Cancer Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
Canine cancer screening is a process used to detect cancer in dogs at an early stage, often before symptoms become noticeable. Early detection can significantly improve the chances of successful treatment. Screening methods may include blood tests, imaging (such as X-rays or ultrasounds), and physical exams. Recently, there has also been progress in genetic testing and liquid biopsy techniques, which involve detecting cancer-related DNA or biomarkers in a dog's blood sample.
United States market for Canine Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Canine Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Canine Cancer Screening is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Canine Cancer Screening players cover IDEXX, Mars Pedtcare, Zoetis, PetDx, Molecular Diagnostics (MDxHealth), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Canine Cancer Screening Industry Forecast” looks at past sales and reviews total world Canine Cancer Screening sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Cancer Screening sales for 2026 through 2032. With Canine Cancer Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Cancer Screening industry.
This Insight Report provides a comprehensive analysis of the global Canine Cancer Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Canine Cancer Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Canine Cancer Screening market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Cancer Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Cancer Screening.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Cancer Screening market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Liquid Biopsy (Blood-Based Tests)
- Tissue Biopsy
- Genomic Testing
- Biomarker Tests
- Veterinary Clinics
- Veterinary Hospitals
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- IDEXX
- Mars Pedtcare
- Zoetis
- PetDx
- Molecular Diagnostics (MDxHealth)
- Biom?rieux SA
- OncoK9
- Antech Diagnostics
- VolitionRx Limited
- Oncotect
- Heska Corporation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Canine Cancer Screening Market Size (2021-2032)
2.1.2 Canine Cancer Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Canine Cancer Screening by Country/Region (2021, 2025 & 2032)
2.2 Canine Cancer Screening Segment by Type
2.2.1 Liquid Biopsy (Blood-Based Tests)
2.2.2 Tissue Biopsy
2.2.3 Genomic Testing
2.2.4 Biomarker Tests
2.2.5 Canine Cancer Screening Market Size by Type
2.2.5.1 Canine Cancer Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Canine Cancer Screening Market Size Market Share by Type (2021-2026)
2.3 Canine Cancer Screening Segment by Application
2.3.1 Veterinary Clinics
2.3.2 Veterinary Hospitals
2.3.3 Other
2.3.4 Canine Cancer Screening Market Size by Application
2.3.4.1 Canine Cancer Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Canine Cancer Screening Market Size Market Share by Application (2021-2026)
3 CANINE CANCER SCREENING MARKET SIZE BY PLAYER
3.1 Canine Cancer Screening Market Size Market Share by Player
3.1.1 Global Canine Cancer Screening Revenue by Player (2021-2026)
3.1.2 Global Canine Cancer Screening Revenue Market Share by Player (2021-2026)
3.2 Global Canine Cancer Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANINE CANCER SCREENING BY REGION
4.1 Canine Cancer Screening Market Size by Region (2021-2026)
4.2 Global Canine Cancer Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Canine Cancer Screening Market Size Growth (2021-2026)
4.4 APAC Canine Cancer Screening Market Size Growth (2021-2026)
4.5 Europe Canine Cancer Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Canine Cancer Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Canine Cancer Screening Market Size by Country (2021-2026)
5.2 Americas Canine Cancer Screening Market Size by Type (2021-2026)
5.3 Americas Canine Cancer Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canine Cancer Screening Market Size by Region (2021-2026)
6.2 APAC Canine Cancer Screening Market Size by Type (2021-2026)
6.3 APAC Canine Cancer Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Canine Cancer Screening Market Size by Country (2021-2026)
7.2 Europe Canine Cancer Screening Market Size by Type (2021-2026)
7.3 Europe Canine Cancer Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Canine Cancer Screening by Region (2021-2026)
8.2 Middle East & Africa Canine Cancer Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Canine Cancer Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANINE CANCER SCREENING MARKET FORECAST
10.1 Global Canine Cancer Screening Forecast by Region (2027-2032)
10.1.1 Global Canine Cancer Screening Forecast by Region (2027-2032)
10.1.2 Americas Canine Cancer Screening Forecast
10.1.3 APAC Canine Cancer Screening Forecast
10.1.4 Europe Canine Cancer Screening Forecast
10.1.5 Middle East & Africa Canine Cancer Screening Forecast
10.2 Americas Canine Cancer Screening Forecast by Country (2027-2032)
10.2.1 United States Market Canine Cancer Screening Forecast
10.2.2 Canada Market Canine Cancer Screening Forecast
10.2.3 Mexico Market Canine Cancer Screening Forecast
10.2.4 Brazil Market Canine Cancer Screening Forecast
10.3 APAC Canine Cancer Screening Forecast by Region (2027-2032)
10.3.1 China Canine Cancer Screening Market Forecast
10.3.2 Japan Market Canine Cancer Screening Forecast
10.3.3 Korea Market Canine Cancer Screening Forecast
10.3.4 Southeast Asia Market Canine Cancer Screening Forecast
10.3.5 India Market Canine Cancer Screening Forecast
10.3.6 Australia Market Canine Cancer Screening Forecast
10.4 Europe Canine Cancer Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Canine Cancer Screening Forecast
10.4.2 France Market Canine Cancer Screening Forecast
10.4.3 UK Market Canine Cancer Screening Forecast
10.4.4 Italy Market Canine Cancer Screening Forecast
10.4.5 Russia Market Canine Cancer Screening Forecast
10.5 Middle East & Africa Canine Cancer Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Canine Cancer Screening Forecast
10.5.2 South Africa Market Canine Cancer Screening Forecast
10.5.3 Israel Market Canine Cancer Screening Forecast
10.5.4 Turkey Market Canine Cancer Screening Forecast
10.6 Global Canine Cancer Screening Forecast by Type (2027-2032)
10.7 Global Canine Cancer Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Canine Cancer Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 IDEXX
11.1.1 IDEXX Company Information
11.1.2 IDEXX Canine Cancer Screening Product Offered
11.1.3 IDEXX Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 IDEXX Main Business Overview
11.1.5 IDEXX Latest Developments
11.2 Mars Pedtcare
11.2.1 Mars Pedtcare Company Information
11.2.2 Mars Pedtcare Canine Cancer Screening Product Offered
11.2.3 Mars Pedtcare Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Mars Pedtcare Main Business Overview
11.2.5 Mars Pedtcare Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Canine Cancer Screening Product Offered
11.3.3 Zoetis Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 PetDx
11.4.1 PetDx Company Information
11.4.2 PetDx Canine Cancer Screening Product Offered
11.4.3 PetDx Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 PetDx Main Business Overview
11.4.5 PetDx Latest Developments
11.5 Molecular Diagnostics (MDxHealth)
11.5.1 Molecular Diagnostics (MDxHealth) Company Information
11.5.2 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Offered
11.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Molecular Diagnostics (MDxHealth) Main Business Overview
11.5.5 Molecular Diagnostics (MDxHealth) Latest Developments
11.6 Biom?rieux SA
11.6.1 Biom?rieux SA Company Information
11.6.2 Biom?rieux SA Canine Cancer Screening Product Offered
11.6.3 Biom?rieux SA Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biom?rieux SA Main Business Overview
11.6.5 Biom?rieux SA Latest Developments
11.7 OncoK9
11.7.1 OncoK9 Company Information
11.7.2 OncoK9 Canine Cancer Screening Product Offered
11.7.3 OncoK9 Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 OncoK9 Main Business Overview
11.7.5 OncoK9 Latest Developments
11.8 Antech Diagnostics
11.8.1 Antech Diagnostics Company Information
11.8.2 Antech Diagnostics Canine Cancer Screening Product Offered
11.8.3 Antech Diagnostics Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Antech Diagnostics Main Business Overview
11.8.5 Antech Diagnostics Latest Developments
11.9 VolitionRx Limited
11.9.1 VolitionRx Limited Company Information
11.9.2 VolitionRx Limited Canine Cancer Screening Product Offered
11.9.3 VolitionRx Limited Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 VolitionRx Limited Main Business Overview
11.9.5 VolitionRx Limited Latest Developments
11.10 Oncotect
11.10.1 Oncotect Company Information
11.10.2 Oncotect Canine Cancer Screening Product Offered
11.10.3 Oncotect Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Oncotect Main Business Overview
11.10.5 Oncotect Latest Developments
11.11 Heska Corporation
11.11.1 Heska Corporation Company Information
11.11.2 Heska Corporation Canine Cancer Screening Product Offered
11.11.3 Heska Corporation Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Heska Corporation Main Business Overview
11.11.5 Heska Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Canine Cancer Screening Market Size (2021-2032)
2.1.2 Canine Cancer Screening Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Canine Cancer Screening by Country/Region (2021, 2025 & 2032)
2.2 Canine Cancer Screening Segment by Type
2.2.1 Liquid Biopsy (Blood-Based Tests)
2.2.2 Tissue Biopsy
2.2.3 Genomic Testing
2.2.4 Biomarker Tests
2.2.5 Canine Cancer Screening Market Size by Type
2.2.5.1 Canine Cancer Screening Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Canine Cancer Screening Market Size Market Share by Type (2021-2026)
2.3 Canine Cancer Screening Segment by Application
2.3.1 Veterinary Clinics
2.3.2 Veterinary Hospitals
2.3.3 Other
2.3.4 Canine Cancer Screening Market Size by Application
2.3.4.1 Canine Cancer Screening Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Canine Cancer Screening Market Size Market Share by Application (2021-2026)
3 CANINE CANCER SCREENING MARKET SIZE BY PLAYER
3.1 Canine Cancer Screening Market Size Market Share by Player
3.1.1 Global Canine Cancer Screening Revenue by Player (2021-2026)
3.1.2 Global Canine Cancer Screening Revenue Market Share by Player (2021-2026)
3.2 Global Canine Cancer Screening Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CANINE CANCER SCREENING BY REGION
4.1 Canine Cancer Screening Market Size by Region (2021-2026)
4.2 Global Canine Cancer Screening Annual Revenue by Country/Region (2021-2026)
4.3 Americas Canine Cancer Screening Market Size Growth (2021-2026)
4.4 APAC Canine Cancer Screening Market Size Growth (2021-2026)
4.5 Europe Canine Cancer Screening Market Size Growth (2021-2026)
4.6 Middle East & Africa Canine Cancer Screening Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Canine Cancer Screening Market Size by Country (2021-2026)
5.2 Americas Canine Cancer Screening Market Size by Type (2021-2026)
5.3 Americas Canine Cancer Screening Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canine Cancer Screening Market Size by Region (2021-2026)
6.2 APAC Canine Cancer Screening Market Size by Type (2021-2026)
6.3 APAC Canine Cancer Screening Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Canine Cancer Screening Market Size by Country (2021-2026)
7.2 Europe Canine Cancer Screening Market Size by Type (2021-2026)
7.3 Europe Canine Cancer Screening Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Canine Cancer Screening by Region (2021-2026)
8.2 Middle East & Africa Canine Cancer Screening Market Size by Type (2021-2026)
8.3 Middle East & Africa Canine Cancer Screening Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CANINE CANCER SCREENING MARKET FORECAST
10.1 Global Canine Cancer Screening Forecast by Region (2027-2032)
10.1.1 Global Canine Cancer Screening Forecast by Region (2027-2032)
10.1.2 Americas Canine Cancer Screening Forecast
10.1.3 APAC Canine Cancer Screening Forecast
10.1.4 Europe Canine Cancer Screening Forecast
10.1.5 Middle East & Africa Canine Cancer Screening Forecast
10.2 Americas Canine Cancer Screening Forecast by Country (2027-2032)
10.2.1 United States Market Canine Cancer Screening Forecast
10.2.2 Canada Market Canine Cancer Screening Forecast
10.2.3 Mexico Market Canine Cancer Screening Forecast
10.2.4 Brazil Market Canine Cancer Screening Forecast
10.3 APAC Canine Cancer Screening Forecast by Region (2027-2032)
10.3.1 China Canine Cancer Screening Market Forecast
10.3.2 Japan Market Canine Cancer Screening Forecast
10.3.3 Korea Market Canine Cancer Screening Forecast
10.3.4 Southeast Asia Market Canine Cancer Screening Forecast
10.3.5 India Market Canine Cancer Screening Forecast
10.3.6 Australia Market Canine Cancer Screening Forecast
10.4 Europe Canine Cancer Screening Forecast by Country (2027-2032)
10.4.1 Germany Market Canine Cancer Screening Forecast
10.4.2 France Market Canine Cancer Screening Forecast
10.4.3 UK Market Canine Cancer Screening Forecast
10.4.4 Italy Market Canine Cancer Screening Forecast
10.4.5 Russia Market Canine Cancer Screening Forecast
10.5 Middle East & Africa Canine Cancer Screening Forecast by Region (2027-2032)
10.5.1 Egypt Market Canine Cancer Screening Forecast
10.5.2 South Africa Market Canine Cancer Screening Forecast
10.5.3 Israel Market Canine Cancer Screening Forecast
10.5.4 Turkey Market Canine Cancer Screening Forecast
10.6 Global Canine Cancer Screening Forecast by Type (2027-2032)
10.7 Global Canine Cancer Screening Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Canine Cancer Screening Forecast
11 KEY PLAYERS ANALYSIS
11.1 IDEXX
11.1.1 IDEXX Company Information
11.1.2 IDEXX Canine Cancer Screening Product Offered
11.1.3 IDEXX Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 IDEXX Main Business Overview
11.1.5 IDEXX Latest Developments
11.2 Mars Pedtcare
11.2.1 Mars Pedtcare Company Information
11.2.2 Mars Pedtcare Canine Cancer Screening Product Offered
11.2.3 Mars Pedtcare Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Mars Pedtcare Main Business Overview
11.2.5 Mars Pedtcare Latest Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Canine Cancer Screening Product Offered
11.3.3 Zoetis Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Zoetis Main Business Overview
11.3.5 Zoetis Latest Developments
11.4 PetDx
11.4.1 PetDx Company Information
11.4.2 PetDx Canine Cancer Screening Product Offered
11.4.3 PetDx Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 PetDx Main Business Overview
11.4.5 PetDx Latest Developments
11.5 Molecular Diagnostics (MDxHealth)
11.5.1 Molecular Diagnostics (MDxHealth) Company Information
11.5.2 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Offered
11.5.3 Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Molecular Diagnostics (MDxHealth) Main Business Overview
11.5.5 Molecular Diagnostics (MDxHealth) Latest Developments
11.6 Biom?rieux SA
11.6.1 Biom?rieux SA Company Information
11.6.2 Biom?rieux SA Canine Cancer Screening Product Offered
11.6.3 Biom?rieux SA Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Biom?rieux SA Main Business Overview
11.6.5 Biom?rieux SA Latest Developments
11.7 OncoK9
11.7.1 OncoK9 Company Information
11.7.2 OncoK9 Canine Cancer Screening Product Offered
11.7.3 OncoK9 Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 OncoK9 Main Business Overview
11.7.5 OncoK9 Latest Developments
11.8 Antech Diagnostics
11.8.1 Antech Diagnostics Company Information
11.8.2 Antech Diagnostics Canine Cancer Screening Product Offered
11.8.3 Antech Diagnostics Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Antech Diagnostics Main Business Overview
11.8.5 Antech Diagnostics Latest Developments
11.9 VolitionRx Limited
11.9.1 VolitionRx Limited Company Information
11.9.2 VolitionRx Limited Canine Cancer Screening Product Offered
11.9.3 VolitionRx Limited Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 VolitionRx Limited Main Business Overview
11.9.5 VolitionRx Limited Latest Developments
11.10 Oncotect
11.10.1 Oncotect Company Information
11.10.2 Oncotect Canine Cancer Screening Product Offered
11.10.3 Oncotect Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Oncotect Main Business Overview
11.10.5 Oncotect Latest Developments
11.11 Heska Corporation
11.11.1 Heska Corporation Company Information
11.11.2 Heska Corporation Canine Cancer Screening Product Offered
11.11.3 Heska Corporation Canine Cancer Screening Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Heska Corporation Main Business Overview
11.11.5 Heska Corporation Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Canine Cancer Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Canine Cancer Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid Biopsy (Blood-Based Tests)
Table 4. Major Players of Tissue Biopsy
Table 5. Major Players of Genomic Testing
Table 6. Major Players of Biomarker Tests
Table 7. Canine Cancer Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Table 10. Canine Cancer Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Table 13. Global Canine Cancer Screening Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Canine Cancer Screening Revenue Market Share by Player (2021-2026)
Table 15. Canine Cancer Screening Key Players Head office and Products Offered
Table 16. Canine Cancer Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Canine Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Table 21. Global Canine Cancer Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Canine Cancer Screening Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Canine Cancer Screening Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Canine Cancer Screening Market Size Market Share by Country (2021-2026)
Table 25. Americas Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Table 27. Americas Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Table 29. APAC Canine Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Table 31. APAC Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Canine Cancer Screening Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Canine Cancer Screening Market Size Market Share by Country (2021-2026)
Table 35. Europe Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Canine Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Canine Cancer Screening
Table 41. Key Market Challenges & Risks of Canine Cancer Screening
Table 42. Key Industry Trends of Canine Cancer Screening
Table 43. Global Canine Cancer Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Canine Cancer Screening Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Canine Cancer Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Canine Cancer Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. IDEXX Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 48. IDEXX Canine Cancer Screening Product Offered
Table 49. IDEXX Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. IDEXX Main Business
Table 51. IDEXX Latest Developments
Table 52. Mars Pedtcare Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 53. Mars Pedtcare Canine Cancer Screening Product Offered
Table 54. Mars Pedtcare Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Mars Pedtcare Main Business
Table 56. Mars Pedtcare Latest Developments
Table 57. Zoetis Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 58. Zoetis Canine Cancer Screening Product Offered
Table 59. Zoetis Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Zoetis Main Business
Table 61. Zoetis Latest Developments
Table 62. PetDx Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 63. PetDx Canine Cancer Screening Product Offered
Table 64. PetDx Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PetDx Main Business
Table 66. PetDx Latest Developments
Table 67. Molecular Diagnostics (MDxHealth) Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 68. Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Offered
Table 69. Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Molecular Diagnostics (MDxHealth) Main Business
Table 71. Molecular Diagnostics (MDxHealth) Latest Developments
Table 72. Biom?rieux SA Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 73. Biom?rieux SA Canine Cancer Screening Product Offered
Table 74. Biom?rieux SA Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Biom?rieux SA Main Business
Table 76. Biom?rieux SA Latest Developments
Table 77. OncoK9 Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 78. OncoK9 Canine Cancer Screening Product Offered
Table 79. OncoK9 Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. OncoK9 Main Business
Table 81. OncoK9 Latest Developments
Table 82. Antech Diagnostics Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 83. Antech Diagnostics Canine Cancer Screening Product Offered
Table 84. Antech Diagnostics Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Antech Diagnostics Main Business
Table 86. Antech Diagnostics Latest Developments
Table 87. VolitionRx Limited Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 88. VolitionRx Limited Canine Cancer Screening Product Offered
Table 89. VolitionRx Limited Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. VolitionRx Limited Main Business
Table 91. VolitionRx Limited Latest Developments
Table 92. Oncotect Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 93. Oncotect Canine Cancer Screening Product Offered
Table 94. Oncotect Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Oncotect Main Business
Table 96. Oncotect Latest Developments
Table 97. Heska Corporation Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 98. Heska Corporation Canine Cancer Screening Product Offered
Table 99. Heska Corporation Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Heska Corporation Main Business
Table 101. Heska Corporation Latest Developments
Table 1. Canine Cancer Screening Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Canine Cancer Screening Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid Biopsy (Blood-Based Tests)
Table 4. Major Players of Tissue Biopsy
Table 5. Major Players of Genomic Testing
Table 6. Major Players of Biomarker Tests
Table 7. Canine Cancer Screening Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Table 10. Canine Cancer Screening Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Table 13. Global Canine Cancer Screening Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Canine Cancer Screening Revenue Market Share by Player (2021-2026)
Table 15. Canine Cancer Screening Key Players Head office and Products Offered
Table 16. Canine Cancer Screening Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Canine Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Table 21. Global Canine Cancer Screening Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Canine Cancer Screening Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Canine Cancer Screening Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Canine Cancer Screening Market Size Market Share by Country (2021-2026)
Table 25. Americas Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Table 27. Americas Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Table 29. APAC Canine Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Table 31. APAC Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Canine Cancer Screening Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Canine Cancer Screening Market Size Market Share by Country (2021-2026)
Table 35. Europe Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Canine Cancer Screening Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Canine Cancer Screening Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Canine Cancer Screening Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Canine Cancer Screening
Table 41. Key Market Challenges & Risks of Canine Cancer Screening
Table 42. Key Industry Trends of Canine Cancer Screening
Table 43. Global Canine Cancer Screening Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Canine Cancer Screening Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Canine Cancer Screening Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Canine Cancer Screening Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. IDEXX Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 48. IDEXX Canine Cancer Screening Product Offered
Table 49. IDEXX Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. IDEXX Main Business
Table 51. IDEXX Latest Developments
Table 52. Mars Pedtcare Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 53. Mars Pedtcare Canine Cancer Screening Product Offered
Table 54. Mars Pedtcare Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Mars Pedtcare Main Business
Table 56. Mars Pedtcare Latest Developments
Table 57. Zoetis Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 58. Zoetis Canine Cancer Screening Product Offered
Table 59. Zoetis Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Zoetis Main Business
Table 61. Zoetis Latest Developments
Table 62. PetDx Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 63. PetDx Canine Cancer Screening Product Offered
Table 64. PetDx Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. PetDx Main Business
Table 66. PetDx Latest Developments
Table 67. Molecular Diagnostics (MDxHealth) Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 68. Molecular Diagnostics (MDxHealth) Canine Cancer Screening Product Offered
Table 69. Molecular Diagnostics (MDxHealth) Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Molecular Diagnostics (MDxHealth) Main Business
Table 71. Molecular Diagnostics (MDxHealth) Latest Developments
Table 72. Biom?rieux SA Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 73. Biom?rieux SA Canine Cancer Screening Product Offered
Table 74. Biom?rieux SA Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Biom?rieux SA Main Business
Table 76. Biom?rieux SA Latest Developments
Table 77. OncoK9 Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 78. OncoK9 Canine Cancer Screening Product Offered
Table 79. OncoK9 Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. OncoK9 Main Business
Table 81. OncoK9 Latest Developments
Table 82. Antech Diagnostics Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 83. Antech Diagnostics Canine Cancer Screening Product Offered
Table 84. Antech Diagnostics Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. Antech Diagnostics Main Business
Table 86. Antech Diagnostics Latest Developments
Table 87. VolitionRx Limited Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 88. VolitionRx Limited Canine Cancer Screening Product Offered
Table 89. VolitionRx Limited Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. VolitionRx Limited Main Business
Table 91. VolitionRx Limited Latest Developments
Table 92. Oncotect Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 93. Oncotect Canine Cancer Screening Product Offered
Table 94. Oncotect Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Oncotect Main Business
Table 96. Oncotect Latest Developments
Table 97. Heska Corporation Details, Company Type, Canine Cancer Screening Area Served and Its Competitors
Table 98. Heska Corporation Canine Cancer Screening Product Offered
Table 99. Heska Corporation Canine Cancer Screening Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Heska Corporation Main Business
Table 101. Heska Corporation Latest Developments
LIST OF FIGURES
Figure 1. Canine Cancer Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Canine Cancer Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Canine Cancer Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Canine Cancer Screening Sales Market Share by Country/Region (2025)
Figure 8. Canine Cancer Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Canine Cancer Screening Market Size Market Share by Type in 2025
Figure 10. Canine Cancer Screening in Veterinary Clinics
Figure 11. Global Canine Cancer Screening Market: Veterinary Clinics (2021-2026) & ($ millions)
Figure 12. Canine Cancer Screening in Veterinary Hospitals
Figure 13. Global Canine Cancer Screening Market: Veterinary Hospitals (2021-2026) & ($ millions)
Figure 14. Canine Cancer Screening in Other
Figure 15. Global Canine Cancer Screening Market: Other (2021-2026) & ($ millions)
Figure 16. Global Canine Cancer Screening Market Size Market Share by Application in 2025
Figure 17. Global Canine Cancer Screening Revenue Market Share by Player in 2025
Figure 18. Global Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Figure 19. Americas Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 20. APAC Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 21. Europe Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 23. Americas Canine Cancer Screening Value Market Share by Country in 2025
Figure 24. United States Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Canine Cancer Screening Market Size Market Share by Region in 2025
Figure 29. APAC Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 30. APAC Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 31. China Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. India Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Canine Cancer Screening Market Size Market Share by Country in 2025
Figure 38. Europe Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 39. Europe Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 40. Germany Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. France Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 54. APAC Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 55. Europe Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 57. United States Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 58. Canada Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 59. Mexico Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 60. Brazil Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 61. China Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 62. Japan Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 63. Korea Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 65. India Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 66. Australia Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 67. Germany Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 68. France Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 69. UK Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 70. Italy Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 71. Russia Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 72. Egypt Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 73. South Africa Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 74. Israel Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 75. Turkey Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 76. Global Canine Cancer Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Canine Cancer Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 1. Canine Cancer Screening Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Canine Cancer Screening Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Canine Cancer Screening Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Canine Cancer Screening Sales Market Share by Country/Region (2025)
Figure 8. Canine Cancer Screening Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Canine Cancer Screening Market Size Market Share by Type in 2025
Figure 10. Canine Cancer Screening in Veterinary Clinics
Figure 11. Global Canine Cancer Screening Market: Veterinary Clinics (2021-2026) & ($ millions)
Figure 12. Canine Cancer Screening in Veterinary Hospitals
Figure 13. Global Canine Cancer Screening Market: Veterinary Hospitals (2021-2026) & ($ millions)
Figure 14. Canine Cancer Screening in Other
Figure 15. Global Canine Cancer Screening Market: Other (2021-2026) & ($ millions)
Figure 16. Global Canine Cancer Screening Market Size Market Share by Application in 2025
Figure 17. Global Canine Cancer Screening Revenue Market Share by Player in 2025
Figure 18. Global Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Figure 19. Americas Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 20. APAC Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 21. Europe Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Canine Cancer Screening Market Size 2021-2026 ($ millions)
Figure 23. Americas Canine Cancer Screening Value Market Share by Country in 2025
Figure 24. United States Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Canine Cancer Screening Market Size Market Share by Region in 2025
Figure 29. APAC Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 30. APAC Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 31. China Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 35. India Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Canine Cancer Screening Market Size Market Share by Country in 2025
Figure 38. Europe Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 39. Europe Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 40. Germany Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 41. France Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Canine Cancer Screening Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Canine Cancer Screening Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Canine Cancer Screening Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Canine Cancer Screening Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 54. APAC Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 55. Europe Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 57. United States Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 58. Canada Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 59. Mexico Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 60. Brazil Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 61. China Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 62. Japan Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 63. Korea Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 65. India Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 66. Australia Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 67. Germany Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 68. France Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 69. UK Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 70. Italy Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 71. Russia Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 72. Egypt Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 73. South Africa Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 74. Israel Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 75. Turkey Canine Cancer Screening Market Size 2027-2032 ($ millions)
Figure 76. Global Canine Cancer Screening Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Canine Cancer Screening Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Canine Cancer Screening Market Size 2027-2032 ($ millions)
